The BBC says it will air a program tonight that claims GlaxoSmithKline distorted trial data in an attempt to gain regulators' approval to use the antidepressant Seroxat as a therapy for children. The report claims that Glaxo covered up the drug's link to teen suicide and hid the fact that the drug had failed clinical trials. Glaxo, though, flatly rejected [1] the report's conclusion, saying it never hid any data and brought the information to the attention of regulators.
- check out the press release [2] from the BBC
- read GSK's statement [1] on the accusations
- read the BBC's online report [3]
ALSO: European regulators have agreed to review Glaxo's pre-pandemic flu vaccine. Report [4]
Related Articles:
Study highlights link between Paxil and suicide. Report [5]
GSK prepares to go head-to-head with Merck. Report [6]
Glaxo forges $2.1B deal for HuMax-CD20. Report [7]
GSK sees success with RLS campaign. Report [8]
Links:
[1] http://www.fiercebiotech.com/node/5403
[2] http://www.fiercebiotech.com/node/5404
[3] http://news.bbc.co.uk/2/hi/health/6308871.stm
[4] http://www.businessweek.com/ap/financialnews/D8MV02900.htm
[5] http://www.fiercebiotech.com/story/study-highlights-link-between-paxil-and-suicide/2006-05-12
[6] http://www.fiercebiotech.com/story/gsk-prepares-to-go-head-to-head-with-merck/2007-01-18
[7] http://www.fiercebiotech.com/story/glaxo-forges-2.1b-deal-for-humax-cd20/2006-12-19
[8] http://www.fiercebiotech.com/story/gsk-sees-success-with-rls-campaign/2006-10-25